These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 22706677

  • 1. Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins.
    Kamitani S, Yamada K, Yamamoto S, Ishimoto Y, Ono T, Saiga A, Hanasaki K.
    Cell Mol Biol Lett; 2012 Sep; 17(3):459-78. PubMed ID: 22706677
    [Abstract] [Full Text] [Related]

  • 2. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2.
    Pruzanski W, Lambeau G, Lazdunski M, Cho W, Kopilov J, Kuksis A.
    Biochim Biophys Acta; 2007 Jan; 1771(1):5-19. PubMed ID: 17197234
    [Abstract] [Full Text] [Related]

  • 3. Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions.
    Ishimoto Y, Yamada K, Yamamoto S, Ono T, Notoya M, Hanasaki K.
    Biochim Biophys Acta; 2003 Oct 21; 1642(3):129-38. PubMed ID: 14572896
    [Abstract] [Full Text] [Related]

  • 4. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X.
    Pruzanski W, Kopilov J, Kuksis A.
    Prostaglandins Other Lipid Mediat; 2016 Jan 21; 122():64-8. PubMed ID: 26711221
    [Abstract] [Full Text] [Related]

  • 5. Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic dyslipidaemia.
    Pettersson C, Fogelstrand L, Rosengren B, Ståhlman S, Hurt-Camejo E, Fagerberg B, Wiklund O.
    J Intern Med; 2008 Aug 21; 264(2):155-65. PubMed ID: 18298481
    [Abstract] [Full Text] [Related]

  • 6. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

  • 7. Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin.
    Gesquiere L, Cho W, Subbaiah PV.
    Biochemistry; 2002 Apr 16; 41(15):4911-20. PubMed ID: 11939786
    [Abstract] [Full Text] [Related]

  • 8. Acidity and lipolysis by group V secreted phospholipase A(2) strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans.
    Lähdesmäki K, Öörni K, Alanne-Kinnunen M, Jauhiainen M, Hurt-Camejo E, Kovanen PT.
    Biochim Biophys Acta; 2012 Feb 16; 1821(2):257-67. PubMed ID: 22041135
    [Abstract] [Full Text] [Related]

  • 9. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
    Pruzanski W, Lambeau L, Lazdunsky M, Cho W, Kopilov J, Kuksis A.
    Biochim Biophys Acta; 2005 Sep 05; 1736(1):38-50. PubMed ID: 16122976
    [Abstract] [Full Text] [Related]

  • 10. Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH.
    Lähdesmäki K, Plihtari R, Soininen P, Hurt-Camejo E, Ala-Korpela M, Oörni K, Kovanen PT.
    Atherosclerosis; 2009 Dec 05; 207(2):352-9. PubMed ID: 19473659
    [Abstract] [Full Text] [Related]

  • 11. Human group X secreted phospholipase A2 induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms.
    Atout R, Karabina SA, Dollet S, Carreras M, Payré C, André P, Lambeau G, Lotteau V, Ninio E, Perrin-Cocon L.
    Atherosclerosis; 2012 Jun 05; 222(2):367-74. PubMed ID: 22494626
    [Abstract] [Full Text] [Related]

  • 12. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.
    Boyanovsky B, Zack M, Forrest K, Webb NR.
    Arterioscler Thromb Vasc Biol; 2009 Apr 05; 29(4):532-8. PubMed ID: 19164803
    [Abstract] [Full Text] [Related]

  • 13. Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids.
    Singh DK, Subbaiah PV.
    J Lipid Res; 2007 Mar 05; 48(3):683-92. PubMed ID: 17148553
    [Abstract] [Full Text] [Related]

  • 14. Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.
    Plihtari R, Hurt-Camejo E, Oörni K, Kovanen PT.
    J Lipid Res; 2010 Jul 05; 51(7):1801-9. PubMed ID: 20124257
    [Abstract] [Full Text] [Related]

  • 15. Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics.
    Yamamoto K, Isogai Y, Sato H, Taketomi Y, Murakami M.
    Anal Bioanal Chem; 2011 Jun 05; 400(7):1829-42. PubMed ID: 21445663
    [Abstract] [Full Text] [Related]

  • 16. Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2).
    Kuksis A, Pruzanski W.
    Lipids; 2017 Jun 05; 52(6):477-488. PubMed ID: 28528433
    [Abstract] [Full Text] [Related]

  • 17. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
    Wooton-Kee CR, Boyanovsky BB, Nasser MS, de Villiers WJ, Webb NR.
    Arterioscler Thromb Vasc Biol; 2004 Apr 05; 24(4):762-7. PubMed ID: 14962950
    [Abstract] [Full Text] [Related]

  • 18. Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines.
    Boyanovsky BB, Li X, Shridas P, Sunkara M, Morris AJ, Webb NR.
    Cytokine; 2010 Apr 05; 50(1):50-7. PubMed ID: 20138782
    [Abstract] [Full Text] [Related]

  • 19. Mitogenic effect of lipoproteins on human vascular smooth muscle cells: the impact of hydrolysis by gr II A phospholipase A(2).
    Pruzanski W, Stefanski E, Kopilov J, Kuksis A.
    Lab Invest; 2001 May 05; 81(5):757-65. PubMed ID: 11351047
    [Abstract] [Full Text] [Related]

  • 20. Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology.
    Curfs DM, Ghesquiere SA, Vergouwe MN, van der Made I, Gijbels MJ, Greaves DR, Verbeek JS, Hofker MH, de Winther MP.
    J Biol Chem; 2008 Aug 01; 283(31):21640-8. PubMed ID: 18511424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.